Green Innovations, subsidiary Green Hygienics announces that major drug store chain selects its Clearly Herbal brand baby wipes for distribution in more than 4,200 US stores

CAPE CORAL, Florida , November 14, 2013 (press release) – Green Innovations Ltd. (OTCQB: GNIN) (OTCBB: GNIN) ("Green Innovations" or the "Company") and the Company's wholly-owned subsidiary, Green Hygienics, Inc. ("Green Hygienics"), is pleased to announce that a major drug store chain has selected its industry-leading national line of Clearly Herbal® brand baby wipes, the Natural Choice®, for distribution in 4,200+ of its stores located throughout the United States. The order is for the Clearly Herbal® line of baby wipes.

"We are pleased to see retailers and their customers embracing our products," said Philip Rundle, CEO of Green Innovations. "Clearly Herbal is an award winning natural based wipe that is sensitive and safe for you and your baby."

Visit for a list of retailers near you.

About Green Innovations Ltd.

Green Innovations Ltd., through its wholly-owned subsidiary, Green Hygienics, Inc. (, is the exclusive licensed North American distributor of American Hygienics Corporation's 100% tree-free bamboo-based product line, including personal care and paper-based goods. The marketplace for tissue paper products, diapers, wet wipes, feminine care products, and adult care products, is in excess of $29 billion annually in the United States. The Company is committed to providing consumers with quality products that are designed and manufactured to the highest standards in FDA-accepted manufacturing facilities without compromising product performance. Green Innovations is a member of the International Green Energy Council (IGEC) and dedicated to ensuring a more healthy and sustainable planet.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.